Logo image of ERO

ERO COPPER CORP (ERO) Stock Fundamental Analysis

NYSE:ERO - New York Stock Exchange, Inc. - CA2960061091 - Common Stock - Currency: USD

12.82  +0.27 (+2.15%)

After market: 12.82 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ERO. ERO was compared to 153 industry peers in the Metals & Mining industry. ERO has a medium profitability rating, but doesn't score so well on its financial health evaluation. ERO is evaluated to be cheap and growing strongly. This does not happen too often!


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year ERO was profitable.
In the past year ERO had a positive cash flow from operations.
Of the past 5 years ERO 4 years were profitable.
In the past 5 years ERO always reported a positive cash flow from operatings.
ERO Yearly Net Income VS EBIT VS OCF VS FCFERO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

ERO has a Return On Assets of -4.70%. This is comparable to the rest of the industry: ERO outperforms 40.52% of its industry peers.
Looking at the Return On Equity, with a value of -11.66%, ERO is doing worse than 63.40% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 8.15%, ERO is in the better half of the industry, outperforming 77.12% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ERO is in line with the industry average of 8.54%.
The 3 year average ROIC (8.14%) for ERO is below the current ROIC(8.15%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -4.7%
ROE -11.66%
ROIC 8.15%
ROA(3y)3.34%
ROA(5y)9.91%
ROE(3y)6.26%
ROE(5y)18.84%
ROIC(3y)8.14%
ROIC(5y)19.2%
ERO Yearly ROA, ROE, ROICERO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

The Operating Margin of ERO (25.72%) is better than 82.35% of its industry peers.
In the last couple of years the Operating Margin of ERO has remained more or less at the same level.
ERO's Gross Margin of 38.39% is amongst the best of the industry. ERO outperforms 81.70% of its industry peers.
In the last couple of years the Gross Margin of ERO has remained more or less at the same level.
Industry RankSector Rank
OM 25.72%
PM (TTM) N/A
GM 38.39%
OM growth 3Y-22.63%
OM growth 5Y-1.37%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.13%
GM growth 5Y-1.36%
ERO Yearly Profit, Operating, Gross MarginsERO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

ERO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ERO has more shares outstanding
The number of shares outstanding for ERO has been increased compared to 5 years ago.
ERO has a worse debt/assets ratio than last year.
ERO Yearly Shares OutstandingERO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ERO Yearly Total Debt VS Total AssetsERO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 1.92 indicates that ERO is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.92, ERO perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
ERO has a Debt/Equity ratio of 0.96. This is a neutral value indicating ERO is somewhat dependend on debt financing.
ERO has a worse Debt to Equity ratio (0.96) than 85.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Altman-Z 1.92
ROIC/WACC0.88
WACC9.24%
ERO Yearly LT Debt VS Equity VS FCFERO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.67 indicates that ERO may have some problems paying its short term obligations.
ERO has a Current ratio of 0.67. This is amonst the worse of the industry: ERO underperforms 88.89% of its industry peers.
A Quick Ratio of 0.46 indicates that ERO may have some problems paying its short term obligations.
With a Quick ratio value of 0.46, ERO is not doing good in the industry: 88.24% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.46
ERO Yearly Current Assets VS Current LiabilitesERO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

7

3. Growth

3.1 Past

ERO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.34%.
Measured over the past years, ERO shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.60% on average per year.
The Revenue has grown by 10.01% in the past year. This is quite good.
Measured over the past years, ERO shows a quite strong growth in Revenue. The Revenue has been growing by 10.55% on average per year.
EPS 1Y (TTM)-10.34%
EPS 3Y-30.56%
EPS 5Y-2.6%
EPS Q2Q%-19.05%
Revenue 1Y (TTM)10.01%
Revenue growth 3Y-1.36%
Revenue growth 5Y10.55%
Sales Q2Q%5.23%

3.2 Future

ERO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 60.64% yearly.
The Revenue is expected to grow by 22.51% on average over the next years. This is a very strong growth
EPS Next Y175.88%
EPS Next 2Y97.55%
EPS Next 3Y64.71%
EPS Next 5Y60.64%
Revenue Next Year67.81%
Revenue Next 2Y41.3%
Revenue Next 3Y27.35%
Revenue Next 5Y22.51%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ERO Yearly Revenue VS EstimatesERO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
ERO Yearly EPS VS EstimatesERO Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3 4 5

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.44 indicates a correct valuation of ERO.
ERO's Price/Earnings ratio is rather cheap when compared to the industry. ERO is cheaper than 81.70% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.18. ERO is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 5.96, the valuation of ERO can be described as very cheap.
95.42% of the companies in the same industry are more expensive than ERO, based on the Price/Forward Earnings ratio.
ERO is valuated cheaply when we compare the Price/Forward Earnings ratio to 20.81, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.44
Fwd PE 5.96
ERO Price Earnings VS Forward Price EarningsERO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ERO indicates a somewhat cheap valuation: ERO is cheaper than 67.97% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.11
ERO Per share dataERO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of ERO may justify a higher PE ratio.
A more expensive valuation may be justified as ERO's earnings are expected to grow with 64.71% in the coming years.
PEG (NY)0.09
PEG (5Y)N/A
EPS Next 2Y97.55%
EPS Next 3Y64.71%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ERO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ERO COPPER CORP

NYSE:ERO (5/2/2025, 8:04:01 PM)

After market: 12.82 0 (0%)

12.82

+0.27 (+2.15%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)03-06 2025-03-06/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners73.35%
Inst Owner Change-0.67%
Ins Owners7.7%
Ins Owner ChangeN/A
Market Cap1.33B
Analysts81.11
Price Target17.92 (39.78%)
Short Float %4.22%
Short Ratio7.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-31.39%
Min EPS beat(2)-44.95%
Max EPS beat(2)-17.83%
EPS beat(4)2
Avg EPS beat(4)0.47%
Min EPS beat(4)-44.95%
Max EPS beat(4)53.36%
EPS beat(8)3
Avg EPS beat(8)-2.28%
EPS beat(12)3
Avg EPS beat(12)-14.58%
EPS beat(16)6
Avg EPS beat(16)-9.12%
Revenue beat(2)0
Avg Revenue beat(2)-18.82%
Min Revenue beat(2)-20.39%
Max Revenue beat(2)-17.25%
Revenue beat(4)1
Avg Revenue beat(4)-9.11%
Min Revenue beat(4)-20.39%
Max Revenue beat(4)4.83%
Revenue beat(8)2
Avg Revenue beat(8)-7.07%
Revenue beat(12)3
Avg Revenue beat(12)-7.72%
Revenue beat(16)7
Avg Revenue beat(16)-2.62%
PT rev (1m)-3.8%
PT rev (3m)-18.71%
EPS NQ rev (1m)-26.29%
EPS NQ rev (3m)-68.44%
EPS NY rev (1m)4.27%
EPS NY rev (3m)-29.52%
Revenue NQ rev (1m)-11.36%
Revenue NQ rev (3m)-38.32%
Revenue NY rev (1m)-3.53%
Revenue NY rev (3m)-15.34%
Valuation
Industry RankSector Rank
PE 16.44
Fwd PE 5.96
P/S 2.82
P/FCF N/A
P/OCF 9.13
P/B 2.26
P/tB 2.26
EV/EBITDA 9.11
EPS(TTM)0.78
EY6.08%
EPS(NY)2.15
Fwd EY16.79%
FCF(TTM)-1.86
FCFYN/A
OCF(TTM)1.4
OCFY10.95%
SpS4.54
BVpS5.67
TBVpS5.67
PEG (NY)0.09
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.7%
ROE -11.66%
ROCE 9.71%
ROIC 8.15%
ROICexc 8.49%
ROICexgc 8.49%
OM 25.72%
PM (TTM) N/A
GM 38.39%
FCFM N/A
ROA(3y)3.34%
ROA(5y)9.91%
ROE(3y)6.26%
ROE(5y)18.84%
ROIC(3y)8.14%
ROIC(5y)19.2%
ROICexc(3y)9.9%
ROICexc(5y)23.79%
ROICexgc(3y)9.9%
ROICexgc(5y)23.79%
ROCE(3y)9.69%
ROCE(5y)22.87%
ROICexcg growth 3Y-45.44%
ROICexcg growth 5Y-14.21%
ROICexc growth 3Y-45.44%
ROICexc growth 5Y-14.21%
OM growth 3Y-22.63%
OM growth 5Y-1.37%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.13%
GM growth 5Y-1.36%
F-Score4
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Debt/EBITDA 2.7
Cap/Depr 386.21%
Cap/Sales 71.79%
Interest Coverage 3.76
Cash Conversion 69.78%
Profit Quality N/A
Current Ratio 0.67
Quick Ratio 0.46
Altman-Z 1.92
F-Score4
WACC9.24%
ROIC/WACC0.88
Cap/Depr(3y)480.9%
Cap/Depr(5y)425.39%
Cap/Sales(3y)82.97%
Cap/Sales(5y)64.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.34%
EPS 3Y-30.56%
EPS 5Y-2.6%
EPS Q2Q%-19.05%
EPS Next Y175.88%
EPS Next 2Y97.55%
EPS Next 3Y64.71%
EPS Next 5Y60.64%
Revenue 1Y (TTM)10.01%
Revenue growth 3Y-1.36%
Revenue growth 5Y10.55%
Sales Q2Q%5.23%
Revenue Next Year67.81%
Revenue Next 2Y41.3%
Revenue Next 3Y27.35%
Revenue Next 5Y22.51%
EBIT growth 1Y27.07%
EBIT growth 3Y-23.68%
EBIT growth 5Y9.03%
EBIT Next Year207.82%
EBIT Next 3Y65.16%
EBIT Next 5Y53.71%
FCF growth 1Y35.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.84%
OCF growth 3Y-26.39%
OCF growth 5Y2.62%